These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2421085)
1. [Correlations of immune system indices in patients with myelomatosis]. Konstantinova NA; Cheredeev AN; Kilikovskiĭ VV; Golenkov AK Lab Delo; 1986; (3):157-9. PubMed ID: 2421085 [No Abstract] [Full Text] [Related]
2. [Studies of tumor necrosis factor-alpha and red cell immunity state in multiple myeloma]. Huang Z; Chen S Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):563-5. PubMed ID: 11263337 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitogen-induced cellular cytotoxicity by serum from patients with multiple myeloma. Papadaki H; Konsolas J; Chatzivassili A; Katrinakis G; Foudoulakis A; Markidou F; Alexandrakis M; Kyriakou D; Eliopoulos GD Haematologia (Budap); 1997; 28(3):123-30. PubMed ID: 9283912 [TBL] [Abstract][Full Text] [Related]
4. [Studies on the function of monocytes from patients with multiple myeloma. IV. Effects of the monocytes on the function of lymphocytes]. Funato T; Watanabe Y; Hayashi M; Koide A; Hirasawa Y; Ohtani H; Saito M Rinsho Byori; 1983 Oct; 31(10):1135-9. PubMed ID: 6674586 [No Abstract] [Full Text] [Related]
5. Immunodeficiency and immunotherapy in multiple myeloma. Pratt G; Goodyear O; Moss P Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051 [TBL] [Abstract][Full Text] [Related]
6. [Status of the immune system in multiple myeloma during polychemotherapy]. Golenkov AK; Cheredeev AN; Zlatkina AR; Konstantinpva NA; Mattes KH Gematol Transfuziol; 1987 Jun; 32(6):9-13. PubMed ID: 3623063 [No Abstract] [Full Text] [Related]
8. Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma. Vacca A; Campobasso N; Iodice G; Ronco M; Dammacco F Chemioterapia; 1985 Apr; 4(2):147-55. PubMed ID: 3924421 [TBL] [Abstract][Full Text] [Related]
9. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease. Hersh EM Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573 [No Abstract] [Full Text] [Related]
11. [Study of immune status indices in workers employed in production of harmful substances]. Vorob'eva AM; Balannik ZT; Kuzovkova SD; Pavlovskaia MN; Smitiuk LA Gig Sanit; 1993 May; (5):21-2. PubMed ID: 8063153 [No Abstract] [Full Text] [Related]
12. [An approach of immunology. Immunological abnormalities in multiple myeloma]. Funato T; Ohtani H Rinsho Byori; 1984 Aug; 32(8):828-34. PubMed ID: 6502981 [No Abstract] [Full Text] [Related]
13. [Dynamics of indices of immune reactivity of the body in patients with chronic cerebral arachnoiditis]. Golovchenko IuI; Makarova TT Vrach Delo; 1988 May; (5):78-80. PubMed ID: 3420880 [No Abstract] [Full Text] [Related]
15. [Changes in the immunity indices of women in occupational contact with synthetic estrogens]. Rotkina IE; Mitrofanov NA Gig Tr Prof Zabol; 1985 Aug; (8):53-4. PubMed ID: 4054659 [No Abstract] [Full Text] [Related]